Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
HYL001, a new potent TGFβ signaling inhibitor that is eff... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
HYL001, a new potent TGFβ signaling inhibitor that is efficacious against microsatellite stable CRC metastasis in combination with immune checkpoint therapy in mice
0
Authors
Daniele Tauriello
•
Carolina Sánchez‐Zarzalejo
15 more
•
Antoni Riéra
Published
May 14, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biochemistry
Cancer Oncology
Immunology
Internal Medicine
Pharmacology
Biology
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1101/2024.05.10.593510
License
cc-no
